Massachusetts General Hospital: Liver Cirrhosis trials
The registry lists 10 Liver Cirrhosis studies with Massachusetts General Hospital as lead sponsor. 6 are open to participants now and 2 have results posted.
Phase 1 1Phase 2 1No phase 9(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Proximal Splenic Artery Embolization (PSAE) for the Treatment of Refractory Ascites in Decompensated CirrhosisNot yet recruitingNCT07755059Not applicable
- Initial Resuscitation for Acute Kidney Injury in CirrhosisRecruitingNCT06525623Not applicable
- Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver CirrhosisRecruitingNCT06265272
- LiverPAL: A Trial of Inpatient Palliative Care for Patients With Advanced Liver DiseaseRecruitingNCT05998330Not applicable
- COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCERRecruitingNCT05692024Phase 1/2
- HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver DiseaseRecruitingNCT05205954Not applicable
- Beyond Confounders: Addressing Source of Measurement Variability and Error in Shear Wave ElastographyCompletedNCT03342560Not applicableResults posted
- Sonoelastography: Ultrasound Method to Measure Liver FibrosisCompletedNCT01747772Not applicableResults posted
- LiverPAL: A Pilot Study of Inpatient Palliative Care for Patients With Advanced Liver DiseaseCompletedNCT04953143Not applicable
- Stratification of Patients With Chronic Liver Disease Using Multi Spectral CTCompletedNCT01825213